Replimune Group, Inc. financial data

Symbol
REPL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
500 Unicorn Park, Woburn, Massachusetts
State of incorporation
Delaware
Fiscal year end
March 31
Latest financial report
Q1 2024 - May 16, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.3K % -32%
Debt-to-equity 23.2 % +63.6%
Return On Equity -48.6 % -35.7%
Return On Assets -39.5 % -25.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 61.4M shares +6.3%
Common Stock, Shares, Outstanding 61.4M shares +8.36%
Entity Public Float 606M USD +24.4%
Common Stock, Value, Issued 61K USD +7.02%
Weighted Average Number of Shares Outstanding, Basic 66.6M shares +14.4%
Weighted Average Number of Shares Outstanding, Diluted 66.6M shares +14.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 175M USD +38.3%
General and Administrative Expense 59.8M USD +18.3%
Operating Income (Loss) -235M USD -32.6%
Nonoperating Income (Expense) 19.4M USD +529%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -215M USD -23.8%
Income Tax Expense (Benefit) 408K USD +41.7%
Net Income (Loss) Attributable to Parent -216M USD -23.8%
Earnings Per Share, Basic -3.24 USD/shares -8.36%
Earnings Per Share, Diluted -3.24 USD/shares -8.36%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 74.5M USD -49.2%
Assets, Current 434M USD -26.8%
Property, Plant and Equipment, Net 10.5M USD +40.2%
Operating Lease, Right-of-Use Asset 4.64M USD -11%
Assets 488M USD -24.6%
Accounts Payable, Current 2.58M USD -51.9%
Liabilities, Current 40.4M USD +19.6%
Operating Lease, Liability, Noncurrent 3.77M USD -14.1%
Other Liabilities, Noncurrent 786K USD +66.5%
Liabilities 113M USD +24%
Accumulated Other Comprehensive Income (Loss), Net of Tax 4.86M USD -15.3%
Retained Earnings (Accumulated Deficit) -701M USD -44.4%
Stockholders' Equity Attributable to Parent 375M USD -32.6%
Liabilities and Equity 488M USD -24.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -185M USD -44.8%
Net Cash Provided by (Used in) Financing Activities 16.3M USD -94.8%
Net Cash Provided by (Used in) Investing Activities 97.2M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 61.4M shares +8.36%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -72.1M USD -277%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 76.2M USD -48.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.04M USD +186%
Deferred Tax Assets, Valuation Allowance 162M USD +42.1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 173M USD +37.9%
Operating Lease, Liability 4.93M USD -10.4%
Depreciation 700K USD 0%
Payments to Acquire Property, Plant, and Equipment 449K USD -58%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -217M USD -29.3%
Lessee, Operating Lease, Liability, to be Paid 6.48M USD -14%
Property, Plant and Equipment, Gross 20.4M USD +38.4%
Operating Lease, Liability, Current 1.16M USD +3.85%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.17M USD +1.74%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.16M USD +3.85%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.55M USD -23.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.14M USD -1.98%
Deferred Tax Assets, Operating Loss Carryforwards 142M USD +51.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 8.67M USD -1.03%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.09M USD -3.64%
Operating Lease, Payments 1.06M USD +4.44%
Additional Paid in Capital 1.07B USD +3.47%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2.66M USD +8.5%
Share-based Payment Arrangement, Expense 8.24M USD +17.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%